Xolair

Xolair (omalizumab) is a prescription medication used to help control symptoms of allergic asthma and chronic hives. It works by targeting and blocking immunoglobulin E (IgE) to reduce allergic reactions. This injectable therapy is designed for long-term management of persistent symptoms. Suitable for adults and adolescents.

Xolair (omalizumab) is used to treat moderate to severe persistent allergic asthma in patients whose symptoms are not adequately controlled by inhaled corticosteroids. It is also approved for chronic idiopathic urticaria (chronic hives) in adults and adolescents who continue to experience symptoms despite antihistamine treatment. People often ask, what is Xolair used for, and it is primarily indicated for these allergic conditions when standard therapies are insufficient.

Xolair helps reduce the frequency and severity of asthma attacks and hive flare-ups by lowering IgE levels in the body. Many users report improved breathing and fewer allergic reactions over time. It is not a rescue medication and should be used as part of a long-term treatment plan. Effects may take several weeks to become noticeable.

Xolair should be administered under medical supervision due to the risk of allergic reactions, including anaphylaxis. Patients with a history of severe allergic reactions should discuss risks with their healthcare provider. Keep emergency medical information accessible after each dose. Store Xolair in the refrigerator and protect it from light.

Limited data exist on drug interactions with Xolair, but caution is advised when combining with other biologics or immunosuppressants. No specific interactions with common medications like antihistamines or inhalers have been reported. Always inform your healthcare provider about all medications and supplements being taken. Alcohol use does not appear to directly interact but may worsen underlying conditions.